MTAP and colorectal carcinoma: In CRC, ERBB2 (8.8% vs 5.1%, P = .008) alterations were more frequently observed while PIK3CA (13.4% vs 19.0%, P = .015) alterations were less frequently observed in homozygous MTAP-loss compared with MTAP-intact tumors.